TABLE 2.
Absorbent | IgG titer to UspA1 in sample:
|
IgG titer to UspA2 in sample:
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 1 | 2 | 3 | 4 | 5 | 6 | |
Noneb | 161,750 | 873,680 | 154,650 | 10,330 | 35,780 | 19,130 | 87,180 | 248,290 | 146,900 | 7,860 | 31,230 | 13,200 |
UspA1 | 2,450 | 2,210 | 3,160 | 1,650 | <500 | 3,010 | 2,800 | 2,120 | 2,700 | 2,220 | <500 | <500 |
UspA2 | 42,620 | 90,150 | 33,570 | 6,420 | 3,490 | 4,130 | <500 | 1,820 | 3,010 | 2,960 | <500 | <500 |
74-kDa protein | 137,530 | 517,970 | 208,240 | 25,930 | 20,570 | 37,570 | 64,760 | 84,590 | 208,240 | 25,930 | 20,570 | 37,570 |
For the absorption, an aliquot of adult serum was diluted and mixed with purified UspA1 or UspA2 from the O35E strain to a final 50-μg/ml protein concentration and a final 1:10 serum dilution. The mixtures were incubated at 4°C for 2 h, and precipitates were removed by microcentrifugation. The titers of IgG to the UspA1 and UspA2 proteins are endpoint titers starting at a serum dilution of 1:500.
Saline was added to these samples in place of purified protein (at an equivalent volume), and samples were treated the same thereafter.